CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...

Diversified healthcare company CVS Health (NYSE:CVS) announced in Q1 CY2025, with sales up 7% year on year to $94.59 billion.

Entrance to a CVS Pharmacy in Manhattan. (Photo by ... More Erik McGregor/LightRocket via ) LightRocket via Getty Imag ...

CVS Health has raised its full-year profit forecast, driven by robust performance across its sectors and strategic restructuring initiatives led by CEO David Joyner. Following a challenging year, the ...

The CODM uses adjusted operating income as its principal measure of segment performance as it ... adjusted income attributable to CVS Health. See "Non-GAAP Financial Information" earlier in ...

The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per share.

Market participants will be closely following the financial results of CVS Health in its upcoming ... correlation with impending stock price performance. To exploit this, we've formed the Zacks ...

Canoe Financial LP has opened a new $94.1M position in $CVS, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 03-31-2025 report period ...

Based on year-to-date results through February, the Company currently expects financial results will meet ... and expertise are well suited to CVS Health and we welcome them both to our leadership ...

WOONSOCKET, R.I., April 8, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced two leadership updates.